Clinical Trial Update: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing nilotinib in combination with standard chemotherapy for newly diagnosed acute lymphoblastic leukemia. Results have been posted after stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)
• Tasigna (nilotinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-07